Henry Ford Health System Chief Academic Officer and neurosurgeon Dr. Steven Kalkanis discusses the new Henry Ford study that found hydroxychloroquine lowered the mortality rate in hospitalized COVID-19 patients when treated early.
Henry Ford Health System Chief Academic Officer and neurosurgeon Dr. Steven Kalkanis discusses the new Henry Ford study that found hydroxychloroquine lowered the mortality rate in hospitalized COVID-19 patients when treated early.
US biotech firm Inovio on Tuesday reported encouraging results in preliminary clinical trials for its Covid-19 vaccine candidate. #Vaccine #Coronavirus #COVID19 #Inovio #DonaldTrump #WarpSpeed #INO4800 Follow us on: Website: Facebook: Twitter: Instagram:
Vaccines train our bodies to recognize and fend off germs before they make us sick. Traditionally, vaccines are made using viruses that have been killed or weakened, like vaccines against the flu or measles. Now scientists are using newer and…